25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China: a Randomized, Single Blind Trial
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms aiRTo-PDR
- 10 Jun 2017 Biomarkers information updated
- 23 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
- 05 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.